Cas:39565-07-6 5,7-dimethyl[1,8]naphthyridin-2-amine manufacturer & supplier

We serve Chemical Name:5,7-dimethyl[1,8]naphthyridin-2-amine CAS:39565-07-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5,7-dimethyl[1,8]naphthyridin-2-amine

Chemical Name:5,7-dimethyl[1,8]naphthyridin-2-amine
CAS.NO:39565-07-6
Synonyms:EINECS 254-516-8;5,7-dimethyl-1,8-naphthyridin-2-amine;MFCD00006732
Molecular Formula:C10H11N3
Molecular Weight:173.21400
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:338.8ºC at 760 mmHg
Density:1.195 g/cm3
Index of Refraction:1.671
PSA:51.80000
Exact Mass:173.09500
LogP:2.41000

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like EINECS 254-516-8 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00006732 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00006732 Use and application,MFCD00006732 technical grade,usp/ep/jp grade.


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. 5,7-dimethyl[1,8]naphthyridin-2-amine manufacturer At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves. 5,7-dimethyl[1,8]naphthyridin-2-amine supplier At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity. 5,7-dimethyl[1,8]naphthyridin-2-amine vendor No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. 5,7-dimethyl[1,8]naphthyridin-2-amine factory At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.